primary tumor control remains major problem treatment locally advanced prostate carcinoma clinical local failure rates approach significantly higher results prostatic biopsy antigen psa levels considered low growth rate cycling fraction prostate adenocarcinoma suggest potential therapeutic advantage high linear energy transfer let neutrons radiation therapy oncology group rtog performed randomized trial rtog comparing mixed beam neutron plus photon irradiation conventional photon irradiation treatment locally advanced prostate cancer subsequent trial neutron therapy collaborative working group ntcwg compared pure neutron irradiation standard photon irradiation randomized trials demonstrate significant improvement locoregional control neutron irradiation compared conventional photon irradiation treatment locally advanced prostate carcinoma date mixed beam trial shown significant survival benefit future analysis larger ntcwg trial point confirm improved locoregional control translates survival advantage findings significant implications local treatment strategies including conformal photon irradiation prostate implantation neutron radiation given large numbers patients afflicted disease positive survival advantage neutrons mixed beam therapy provide strong incentive development economically feasible clinical neutron facilities references NUMBER NUMBER NUMBER prostate specific multi institutional NUMBER NUMBER NUMBER NUMBER NUMBER year dose escalated